David Jackson
0000-0002-4448-8648
1 paper found
Refreshing results…
Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial
Missing publications? Search for publications with a matching author name.